Article info
PDFOvarian Cancer
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?
- Address correspondence and reprint requests to Karin Leunen, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. E-mail: karin.leunen{at}uz.kuleuven.ac.be.
Citation
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?
Publication history
- Received March 25, 2009
- First published November 1, 2009.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2009 by IGCS and ESGO